Asep Medical Holdings Inc. (SEPSF)
Sector: In Vitro & In Vivo Diagnostic Substances
Industry: Biotechnology
Asep Medical Holdings Inc
OTC:SEPSFHealthcare · Biotechnology
Mkt Cap-
EV-
Float6.58M
O/S10.86M
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
MCap-Float6.58MO/S10.86M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Nov 9, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Nov 6, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Nov 3, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Nov 2, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 30, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 29, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 26, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 23, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 20, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 19, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 16, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 15, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 12, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 9, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 6, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
| Oct 5, 2026 | 0.0109 | 0.0109 | 0.0109 | 0.0109 | 20 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources:
About
Asep Medical Holdings Inc., operating primarily through its subsidiary ASEP Medical Inc., is dedicated to advancing both a rapid diagnostic system for Sepsis and a range of peptide-based therapeutic treatments applicable across various medical conditions.
The company, initially incorporated in 2020 under the name Trenchant Life Sciences Investment Corp., later rebranded to its present title, Asep Medical Holdings Inc.
Its corporate base of operations is located in Vancouver, Canada.
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
SectorHealthcare
IndustryBiotechnology
ExchangeOTC
Country
CA
IPO Date-
Shares Outstanding10.86M
Authorized Shares
Float6.58M
52-Week Range
Volume
Average Daily Volume--
30d Avg
--
60d Avg
--
90d Avg
--
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...